Silke Mühlah

Title: Silke Mühlah: Innovator in Pharmaceutical Formulations

Introduction

Silke Mühlah is a notable inventor based in Biberach, Germany. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative drug delivery systems. Her work focuses on creating stable and effective formulations that enhance the release of active compounds.

Latest Patents

Silke Mühlah holds a patent for a "Matrix for sustained, invariant and independent release of active compounds." This invention pertains to a storage-stable pharmaceutical formulation that comprises two active compounds in a non-swellable diffusion matrix. The unique aspect of her invention is that the compounds are released from the matrix in a sustained, invariant manner, and if multiple compounds are present, they are released independently. The matrix is characterized by its substantial release properties, which are determined by ethylcellulose and at least one fatty alcohol. Additionally, her patent includes methods for producing such pharmaceutical formulations.

Career Highlights

Silke Mühlah is associated with Euro-Celtique S.a., where she has been instrumental in advancing pharmaceutical technologies. Her expertise in formulation science has positioned her as a key player in the industry, contributing to the development of innovative solutions for drug delivery.

Collaborations

Silke has collaborated with notable colleagues, including Christof Spitzley and Bianca Brögmann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Silke Mühlah's contributions to pharmaceutical formulations exemplify her commitment to innovation in drug delivery systems. Her patent and collaborative efforts highlight her role as a leading inventor in the industry.